CoChat

A review and update on the current status of retinal prostheses (bionic eye)

Luo, Y. H.- L., da Cruz, L. · 2014 · British Medical Bulletin
Cited by 89

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

INTRODUCTION/BACKGROUND: The Argus® II is the first retinal prosthesis approved for the treatment of patients blind from retinitis pigmentosa (RP), receiving CE (Conformité Européenne) marking in March 2011 and FDA approval in February 2013. Alpha-IMS followed closely and obtained CE marking in July 2013. Other devices are being developed, some of which are currently in clinical trials. SOURCES OF DATA: A systematic literature search was conducted on PubMED, Google Scholar and IEEExplore. AREAS OF AGREEMENT: Retinal prostheses play a part in restoring vision in blind RP patients providing stable, safe and long-term retinal stimulation. AREAS OF CONTROVERSY: Objective improvement in visual function does not always translate into consistent improvement in the patient's quality of life. Controversy exists over the use of an external image-capturing device versus internally placed photodiode devices. GROWING POINTS: The alpha-IMS, a photovoltaic-based retinal prosthesis recently obtained its CE marking in July 2013. AREAS TIMELY FOR DEVELOPING RESEARCH: Improvement in retinal prosthetic vision depends on: (i) improving visual resolution, (ii) improving the visual field, (iii) developing an accurate neural code for image processing and (iv) improving the biocompatibility of the device to ensure longevity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bmb/ldu002

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 89

Metadata

Authors
Luo, Y. H. L., & da Cruz, L.
Venue
British Medical Bulletin
Published
2014-02-12
Volume
109
Issue
1
Pages
31-44
ISSN
  • 0007-1420 (ISSN-L)
  • 1471-8391
OpenAlex
W2150151463
Cited by
89
References
13
FWCI
5.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.